Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$233.45 - $247.73 $560,280 - $594,552
-2,400 Reduced 48.98%
2,500 $618,000
Q4 2023

Feb 14, 2024

BUY
$232.24 - $267.23 $371,584 - $427,568
1,600 Added 48.48%
4,900 $1.19 Million
Q3 2023

Nov 15, 2023

BUY
$254.9 - $283.59 $841,170 - $935,846
3,300 New
3,300 $853,000
Q4 2022

Feb 14, 2023

SELL
$218.29 - $256.91 $742,186 - $873,494
-3,400 Reduced 79.07%
900 $228,000
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $219,429 - $1.14 Million
4,300 New
4,300 $956,000
Q2 2022

Aug 15, 2022

SELL
$234.74 - $275.42 $492,954 - $578,382
-2,100 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$243.64 - $270.48 $511,644 - $568,008
2,100 New
2,100 $559,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.